Physician profile
Christopher C Carpenter
NPI 1538132311
$1,514.80
in general payments reported to CMS, 2019-2025
15 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $344 · 2021: $161 · 2022: $190 · 2023: $246 · 2024: $186 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613 · Entertainment: $36.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.66 |
| Entertainment | $36.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $489.61 | 2019-2025 | Misight Contact Lens, Biofinity Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $309.86 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $257.82 | 2020-2024 | Total30, Precision 1 |
| Abb Con-Cise Optical Group LLC | $128.05 | 2019-2024 | Spectacle Lenses, Contact Lens |
| Glaukos Corporation | $70.00 | 2025 | Istent Infinite, Idosetr |
| Allergan, INC. | $57.57 | 2022 | |
| Optos, INC. | $36.08 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $35.58 | 2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $22.34 | 2021 | |
| Abbvie INC. | $21.44 | 2023 | Lumigan, Vuity |
| Novartis Pharmaceuticals Corporation | $18.16 | 2021 | |
| Sun Pharmaceutical Industries INC. | $18.12 | 2019 | |
| Bausch & Lomb Americas INC. | $18.09 | 2025 | Infuse |
| Visioneering Technologies, INC. | $17.71 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.